ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382049 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382049; 2) Community: the network communities that were significantly associated with the response to NSC 382049; 3) Molecule: the relationships between components within communities and NSC 382049; 4) MDR: the compounds that were significantly associated with the NSC 382049.

NSC Compound Enrichment Correlation
NSC 683787 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-methyl- 0.0181211508101517 0.54747666
NSC 701570 Androst-5-en-17-one, 3-acetyloxy-16-phenylmethylene-, 17-oxime, (3.beta.)- 0.0181211508101517 0.19442477
NSC 709482 Null 0.0181211508101517 0.36358393
NSC 714407 Null 0.0181211508101517 -0.29038752
NSC 750746 (E)-1-(3,4-dimethoxyphenyl)-3-(2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl)prop-2-en-1-one 0.0181211508101517 0.37280611
NSC 756619 Null 0.0181211508101517 -0.28687535
NSC 762583 Null 0.0181211508101517 -0.1212083
NSC 127755 Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI) 0.0181211508101519 0.76690783
NSC 363812 Tetraplatin 0.0181211508101519 0.64529105
NSC 36437 14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) 0.0181211508101519 0.39083037
Total:136  Current:56    [First] [Prev] [Next] [Last]